Pacira BioSciences Inc (NAS:PCRX)
$ 17.24 -0.46 (-2.6%) Market Cap: 796.03 Mil Enterprise Value: 986.64 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 71/100

Pacira Biosciences Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 08:00AM GMT
Release Date Price: $50 (-2.00%)
Glen Santangelo
Jefferies Financial Group Inc. - MD

Okay. Is this on? Yeah, perfect. Why don't we get started. Thanks, everyone, for joining us this morning, and welcome to the Jefferies London Healthcare Conference. My name is Glen Santangelo. I cover the spec pharma space at Jefferies and the healthcare information technology sector.

Today, we are excited to have Pacira BioSciences here with us today. To my right is Dave Stack, the Chairman and CEO of the company. In the audience, we have Charlie Reinhart, who is the CFO of the company; and way down to his left is Susan Mesco, who heads the Investor Relations for the company. So if you have any questions you should feel free to reach out to Susan.

Our presentation is scheduled to be 30 minutes this morning, but Dave was kind enough to want to leave a few minutes for any questions from the audience. So maybe we'll knock-off a couple of minutes early and just see if there's any questions from any investors in the crowd. So Dave, welcome, thanks for joining us.

I thought maybe a good place to start is just for anyone who's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot